Archives

by in
Entry Author Date Location
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
Sarepta Drug Helps Boys With Duchenne to Walk; Shares Boom 10/03/12 Boston
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Sarepta’s Muscular Dystrophy Drug Improves With Time; Stock Booms 07/24/12 Seattle
Halo Gathers $1.1M From Patient Groups for Muscular Dystrophy Drug 05/24/12 Boston
N-Gene Digs Up Funds to Boost “Heat Shock” Drug in Diabetes and MD 04/25/12 New York
AVI Biopharma Mulls Deal After Mixed Data With Muscular Dystrophy Drug 04/06/12 Seattle
AVI Biopharma Passes Small Study in Muscular Dystrophy 04/02/12 Seattle
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract 12/12/11 Seattle
AVI Starts Duchenne Trial 08/15/11 Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News 06/09/11 Seattle
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Regulus Names Chief Scientist 04/18/11 San Diego
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News 04/07/11 Seattle
AVI Biopharma Adds $30M 04/01/11 Seattle
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News 03/31/11 Seattle
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News 01/06/11 Seattle
AVI Partners With Karolinska 01/05/11 Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News 12/16/10 Seattle
AVI Names New CEO 12/13/10 Seattle
Acceleron Snags $498M Deal With Shire to Develop Muscular Dystrophy Drugs 09/09/10 Boston
Tekmira and AVI Win Ebola Deals, Mirador’s Idea to Prevent Hospital Errors, Tom Ranken’s New Mission, & More Seattle-Area Life Sciences News 07/22/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
AVI Biopharma Ousts CEO Les Hudson in Boardroom Coup 04/21/10 Seattle
Cell Therapeutics Nears Judgment Day, AVI Biopharma Awaits Results, HemaQuest Gets $6M & More Seattle-Area Life Sciences News 02/04/10 Seattle
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
Page 1 of 3 next page »